| Title | Current Vascular Pharmacology |
| Abbreviation | Curr. Vasc. Pharmacol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1) |
| h-index | 69 |
| Overall Rank/Ranking | 4514 |
| SCImago Journal Rank (SJR) | 0.991 |
| Impact Score | 2.23 |
| Publisher | Bentham Science Publishers B.V. |
| Country | United Arab Emirates |
| ISSN | 15701611, 18756212 |
| Best Quartile | Q1 |
| Coverage History | 2003-2023 |
Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention. Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved.
Current Vascular Pharmacology publishes clinical and research-based reviews and debates to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.
Current Vascular Pharmacology is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1). It is published by Bentham Science Publishers B.V.. The overall rank of Current Vascular Pharmacology is 4514. According to SCImago Journal Rank (SJR), this journal is ranked 0.991. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 69. The best quartile for this journal is Q1.
The ISSN of Current Vascular Pharmacology journal is 15701611, 18756212. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Vascular Pharmacology is cited by a total of 702 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Current Vascular Pharmacology is 2.23, which is computed in 2024 as per its definition. Current Vascular Pharmacology IF is decreased by a factor of 1.63 and approximate percentage change is -42.23% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Current Vascular Pharmacology is 2.23. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.23 |
| 2022 | 3.86 |
| 2021 | 3.17 |
| 2020 | 2.17 |
| 2019 | 2.09 |
| 2018 | 1.90 |
| 2017 | 1.71 |
| 2016 | 2.14 |
| 2015 | 2.21 |
| 2014 | 2.46 |
Current Vascular Pharmacology has an h-index of 69. It means 69 articles of this journal have more than 69 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Current Vascular Pharmacology is 15701611, 18756212. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Current Vascular Pharmacology is 4514. According to SCImago Journal Rank (SJR), this journal is ranked 0.991. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.991 |
| 2022 | 0.917 |
| 2021 | 0.670 |
| 2020 | 0.806 |
| 2019 | 0.559 |
| 2018 | 0.605 |
| 2017 | 0.715 |
| 2016 | 0.890 |
| 2015 | 0.897 |
| 2014 | 0.828 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4514 |
| 2022 | 4842 |
| 2021 | 7235 |
| 2020 | 5983 |
| 2019 | 8861 |
| 2018 | 7969 |
| 2017 | 6610 |
| 2016 | 5132 |
| 2015 | 5123 |
| 2014 | 5484 |
Current Vascular Pharmacology is published by Bentham Science Publishers B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2003-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Current Vascular Pharmacology is Curr. Vasc. Pharmacol.. This abbreviation ('Curr. Vasc. Pharmacol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Current Vascular Pharmacology latest impact IF is 2.23. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.86 (2022) and 1.71 (2017), respectively, in the last 10 years. Moreover, its average IS is 2.39 in the previous 10 years.
The Current Vascular Pharmacology has an SJR (SCImago Journal Rank) of 0.991, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.991 in 2023 and the lowest being 0.559 in 2019. Furthermore, the average SJR of the Current Vascular Pharmacology over the previous 10-year period stands at 2.39.
The latest h-index of the Current Vascular Pharmacology is 69.
The Current Vascular Pharmacology is published by the Bentham Science Publishers B.V., with its country of publication being the United Arab Emirates.
The Current Vascular Pharmacology is currently ranked 4514 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 4514 in 2023 and its lowest position of 8861 in 2019.
The standard ISO4 abbreviation for the Current Vascular Pharmacology is Curr. Vasc. Pharmacol..
Current Vascular Pharmacology is classified as a journal that the Bentham Science Publishers B.V. publishes.
The Current Vascular Pharmacology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Current Vascular Pharmacology is assigned the following International Standard Serial Numbers (ISSN): 15701611, 18756212.
The best quartile for the Current Vascular Pharmacology is Q1 (2023).
The Current Vascular Pharmacology coverage history can be summarized as follows: 2003-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| Journal of Geriatric Physical Therapy | journal | 9578 | Lippincott Williams and Wilkins Ltd. | 47 | 1.23 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| International Journal of Mathematical Education in Science and Technology | journal | 8417 | Taylor and Francis Ltd. | 42 | 1.17 |
| European Journal of Education | journal | 4662 | Wiley-Blackwell Publishing Ltd | 59 | 3.64 |
| Howard Journal of Communications | journal | 10151 | Taylor and Francis Ltd. | 39 | 1.66 |
| Studies in Continuing Education | journal | 7550 | Routledge | 40 | 3.04 |
| Acta Periodica Technologica | journal | 23723 | University of Novi Sad, Faculty of Technology | 21 | 0.31 |
| Proceedings of the Royal Society of Queensland | journal | 21886 | Royal Society of Queensland | 12 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 2.23 |
| 2022 | 3.86 |
| 2021 | 3.17 |
| 2020 | 2.17 |
| 2019 | 2.09 |
| 2018 | 1.90 |
| 2017 | 1.71 |
| 2016 | 2.14 |
| 2015 | 2.21 |
| 2014 | 2.46 |
